BACKGROUND: African Americans continue to suffer disproportionately from cancer morbidity and mortality, with emerging evidence suggesting potential quality of life (QOL) disparities in the survivorship period. OBJECTIVE: The objective of the study was to assess sociodemographic, clinical, and psychosocial factors associated with physical and mental health QOL (PHQOL and MHQOL) among African American and white cancer survivors. METHODS: Patients were recruited from tumor registries. Telephone interviews were conducted with 248 African American and 244 white respondents with a history of breast, prostate, or colorectal cancers. Multivariate regression models were used to assess what factors were associated with PHQOL and MHQOL. RESULTS: Key racial differences in adjusted analyses included poorer MHQOL scores among African Americans compared with white survivors. Furthermore, race moderated the relationship between perceived social support and MHQOL, where higher social support levels were associated with increased MHQOL among African Americans. Other correlates of QOL impacted racial groups similarly. For example, factors associated with PHQOL scores included being unemployed, being uninsured, the presence of medical comorbidities, a longer time since diagnosis, and higher levels of cancer-related stress appraisals. Factors associated with MHQOL scores included being unemployed, higher levels of daily stress, higher levels of stress associated with the diagnosis, higher levels of education, higher levels of perceived social support, and higher levels of spirituality. CONCLUSION: Interventions aimed at increasing social support may have important implications for improving QOL outcomes among African Americans. IMPLICATIONS FOR PRACTICE: Measuring and understanding factors associated with QOL have important implications for patient adjustment and clinical decision making.
BACKGROUND: African Americans continue to suffer disproportionately from cancer morbidity and mortality, with emerging evidence suggesting potential quality of life (QOL) disparities in the survivorship period. OBJECTIVE: The objective of the study was to assess sociodemographic, clinical, and psychosocial factors associated with physical and mental health QOL (PHQOL and MHQOL) among African American and white cancer survivors. METHODS:Patients were recruited from tumor registries. Telephone interviews were conducted with 248 African American and 244 white respondents with a history of breast, prostate, or colorectal cancers. Multivariate regression models were used to assess what factors were associated with PHQOL and MHQOL. RESULTS: Key racial differences in adjusted analyses included poorer MHQOL scores among African Americans compared with white survivors. Furthermore, race moderated the relationship between perceived social support and MHQOL, where higher social support levels were associated with increased MHQOL among African Americans. Other correlates of QOL impacted racial groups similarly. For example, factors associated with PHQOL scores included being unemployed, being uninsured, the presence of medical comorbidities, a longer time since diagnosis, and higher levels of cancer-related stress appraisals. Factors associated with MHQOL scores included being unemployed, higher levels of daily stress, higher levels of stress associated with the diagnosis, higher levels of education, higher levels of perceived social support, and higher levels of spirituality. CONCLUSION: Interventions aimed at increasing social support may have important implications for improving QOL outcomes among African Americans. IMPLICATIONS FOR PRACTICE: Measuring and understanding factors associated with QOL have important implications for patient adjustment and clinical decision making.
Authors: Chanita H Halbert; James Coyne; Benita Weathers; Brandon Mahler; Ernestine Delmoor; David Vaughn; S Bruce Malkowicz; David Lee; Andrea Troxel Journal: Urology Date: 2010-03-07 Impact factor: 2.649
Authors: H Okamura; T Watanabe; M Narabayashi; N Katsumata; M Ando; I Adachi; T Akechi; Y Uchitomi Journal: Breast Cancer Res Treat Date: 2000-05 Impact factor: 4.872
Authors: Adam A Garsa; Daniel J Ferraro; Todd A DeWees; Teresa L Deshields; Julie A Margenthaler; Amy E Cyr; Michael Naughton; Rebecca Aft; William E Gillanders; Timothy Eberlein; Melissa A Matesa; Laura L Ochoa; Imran Zoberi Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-22 Impact factor: 7.038
Authors: Kimlin Tam Ashing; Aria M Miller; Eudora Mitchell; Virginia Martin; Kommah McDowell; Rhonda Santifer; June Smith; Shirley Brown; Camille Ragin; Agatha Carrington Journal: Breast Cancer Manag Date: 2014
Authors: Sarah J Skuli; Jennifer Y Sheng; Elissa T Bantug; Nelli Zafman; Carol Riley; Jessica M Ruck; Katherine C Smith; Claire F Snyder; Karen L Smith; Vered Stearns; Antonio C Wolff Journal: Breast Cancer Res Treat Date: 2018-11-07 Impact factor: 4.872
Authors: Laura C Pinheiro; Cleo A Samuel; Katherine E Reeder-Hayes; Stephanie B Wheeler; Andrew F Olshan; Bryce B Reeve Journal: Breast Cancer Res Treat Date: 2016-09-01 Impact factor: 4.872
Authors: Andrew G Matthew; Shabbir M H Alibhai; Tal Davidson; Kristen L Currie; Haiyan Jiang; Murray Krahn; Neil E Fleshner; Robin Kalnin; Alyssa S Louis; B Joyce Davison; John Trachtenberg Journal: Qual Life Res Date: 2014-03-09 Impact factor: 4.147
Authors: Harveshp D Mogal; Marissa Howard-McNatt; Rebecca Dodson; Nora F Fino; Clancy J Clark Journal: Support Care Cancer Date: 2016-12-16 Impact factor: 3.603